Toxoplasma gondii in Cats: Life Cycle, Zoonotic Risk, and Veterinary Management

Etiology and Life Cycle

Toxoplasma gondii is an obligate intracellular apicomplexan parasite that infects virtually all warm-blooded vertebrates, with felids serving as the definitive hosts [1, 2]. The parasite exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts) [3, 4]. The life cycle is heteroxenous, involving both sexual replication in the feline intestinal epithelium and asexual replication in intermediate hosts [5, 6].

The toxoplasmosis cat life cycle begins when a cat ingests tissue cysts containing bradyzoites from infected prey (e.g., rodents, birds) or, less commonly, sporulated oocysts from the environment [7, 8]. After ingestion, bradyzoites are released in the stomach and small intestine, invade enterocytes, and undergo a series of asexual schizogonic divisions (types A–E) [9, 10]. This is followed by gametogony, producing macrogametes and microgametes; fertilization yields unsporulated oocysts that are shed in feces [11, 12]. Oocyst shedding begins 3–10 days post-infection and typically lasts 1–3 weeks, during which millions of oocysts can be excreted [13, 14]. Unsporulated oocysts are non-infectious; sporulation occurs in the environment within 1–5 days under adequate temperature and humidity, yielding two sporocysts each containing four sporozoites [15, 16].

Recent single-cell transcriptomic studies have elucidated the transcriptional landscape of sexual development in the feline intestinal tract, identifying stage-specific gene expression patterns that govern gametocyte formation and oocyst wall biogenesis [17]. The pre-sexual stages (schizonts) undergo a specialized cell division characterized by endopolygeny, a process distinct from the endodyogeny seen in tachyzoites [15]. Loss of glutaredoxin 5 (TGME49_227100) disrupts oocyst formation and sporulation, highlighting a critical redox pathway for environmental transmission [18].

After the initial enteric cycle, tachyzoites disseminate via the lymphatics and bloodstream to extraintestinal tissues, where they convert to bradyzoites within intracellular cysts, particularly in neural and muscular tissues [19, 20]. This latent stage persists for the life of the host and represents a source of recrudescence in immunocompromised individuals [21, 22].

Zoonotic Risk and Transmission

Cats are the only definitive hosts capable of shedding oocysts, making them the primary source of environmental contamination with T. gondii [23, 24]. Oocysts are extremely resilient, surviving for months to years in soil, water, and on surfaces [25, 26]. Humans become infected primarily through ingestion of sporulated oocysts (via contaminated food, water, or hands) or through consumption of undercooked meat containing tissue cysts [27, 28]. Vertical transmission (transplacental) occurs in humans and many animal species when primary infection occurs during gestation [9, 29].

Seroprevalence studies in cats vary widely by geographic region and management practices. In Dhaka City, Bangladesh, seroprevalence reached 47.5% with molecular detection in 12.5% of fecal samples [30]. In Jordan, seroprevalence was 32.1% with risk factors including outdoor access and raw meat feeding [31]. In Hong Kong, community cats showed higher seroprevalence (38.2%) than privately-owned cats (14.7%) [16]. In Golestan Province, Iran, street cats had significantly higher infection rates (58.3%) than domestic cats (29.2%) [6]. In Bangkok, stray cats showed 15.8% PCR positivity in feces [19]. In Thailand's Pathum Thani province, 21.4% of pet cats were seropositive [20]. In the United States, a large fecal survey found T. gondii oocysts in 0.9% of feline samples [13].

Molecular typing reveals substantial genetic diversity among T. gondii isolates. Multilocus sequence typing in China identified clonal lineages (Type I, II, III) and atypical genotypes circulating in cats and other hosts [2]. In Pakistan, molecular profiling of domestic cats detected T. gondii DNA in 8.3% of blood samples, with co-infections with Anaplasma ovis and Bartonella sp. [7]. These data underscore the role of cats as sentinels for environmental contamination.

Occupational exposure is a recognized risk. Veterinary professionals and students in Mexico showed seroprevalence of 18.2%, significantly higher than the general population [10]. In Brazil, social marginalisation and environmental degradation were associated with increased T. gondii exposure in urban informal settlements, highlighting the interplay of socioeconomic factors and zoonotic risk [1].

Clinical Signs in Cats

Most immunocompetent cats infected with T. gondii remain asymptomatic [26, 30]. Clinical disease, termed feline toxoplasmosis, occurs primarily in kittens, immunosuppressed cats, or those with concurrent infections [31, 32]. The most common clinical manifestations are referable to the respiratory, gastrointestinal, and nervous systems.

Acute toxoplasmosis may present with fever, lethargy, anorexia, dyspnea (due to interstitial pneumonia), icterus (from hepatic involvement), and abdominal pain [20, 22]. Ocular signs include anterior uveitis, chorioretinitis, and optic neuritis [26]. Neurological signs (seizures, ataxia, circling, behavioral changes) result from meningoencephalitis or focal granulomas [25, 28]. Myocarditis can cause arrhythmias and congestive heart failure [29].

In pregnant queens, transplacental transmission can lead to abortion, stillbirth, or neonatal death [5, 9]. Kittens infected in utero may develop generalized toxoplasmosis with hepatic necrosis, pneumonitis, and encephalitis [28, 29].

Chronic infection is typically subclinical, but recrudescence can occur under immunosuppression (e.g., feline leukemia virus, feline immunodeficiency virus, or corticosteroid therapy) [21, 22]. The MIC17A protein has been proposed as a marker for both entero-epithelial and chronic stage infection, offering potential for improved serodiagnosis [26].

Diagnostic Approaches

Diagnosis of feline toxoplasmosis relies on a combination of serology, molecular detection, and clinical assessment [3, 32].

Serology: Detection of anti-T. gondii IgG and IgM antibodies is the most common approach. Commercial ELISA kits and indirect immunofluorescence assays are widely used [3, 14]. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed for multi-species detection, including cats, with high sensitivity and specificity [3]. A SAG1-based colloidal gold strip for swine has potential cross-species applicability [14]. Seroprevalence studies in cats consistently report IgG positivity rates ranging from 15% to 60% depending on region and risk factors [6, 16, 20, 30, 31].

Molecular detection: PCR targeting the B1 gene or 529 bp repeat element is the gold standard for detecting T. gondii DNA in blood, tissues, or feces [19, 30, 32]. An antisense PCR assay has been developed to improve sensitivity in domestic cats [32]. Real-time PCR allows quantification of parasite burden. Fecal PCR is useful for detecting oocyst shedding, though shedding is intermittent and short-lived [13, 19].

Fecal examination: Microscopic detection of oocysts (10–12 μm, subspherical) by centrifugal flotation (Sheather's sugar solution) is diagnostic but requires differentiation from other coccidia (e.g., Hammondia hammondi, Besnoitia spp.) [13]. Sensitivity is low due to intermittent shedding.

Histopathology and immunohistochemistry: Tissue biopsy (e.g., lung, liver, brain) can reveal tachyzoites, tissue cysts, and associated inflammation [28, 29]. Immunohistochemical staining using anti-T. gondii antibodies confirms the diagnosis.

Advanced diagnostics: Single-cell RNA sequencing and microRNA expression profiling in feline small intestine during infection have identified novel biomarkers for sexual stage development [17, 22]. These tools are primarily research-oriented but may inform future diagnostic targets.

The following table summarizes diagnostic methods for feline toxoplasmosis:

Veterinary Management and Treatment

Treatment is indicated only for cats with clinical toxoplasmosis, not for latent infections [21, 26]. The standard therapeutic regimen targets the tachyzoite stage and does not eliminate tissue cysts.

First-line therapy: Clindamycin (10–12 mg/kg orally or intramuscularly every 12 hours for 4 weeks) is the drug of choice [21, 22]. It inhibits protein synthesis in apicoplasts. Alternative antibiotics include trimethoprim-sulfonamide combinations (15 mg/kg every 12 hours) and azithromycin (10 mg/kg every 24 hours) [26, 32].

Supportive care: Fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids (e.g., prednisolone 1–2 mg/kg/day) are used for ocular or neurological inflammation [25, 28]. Anticonvulsants may be required for seizure control.

Monitoring: Clinical response is assessed by resolution of fever, respiratory signs, and neurological deficits. Serology is not useful for monitoring treatment efficacy as antibody titers persist [20, 30]. Repeat PCR may document clearance of parasitemia.

Prognosis: With prompt treatment, most cats recover fully. Mortality is higher in kittens and immunocompromised individuals [29, 31].

Prevention and Control

Preventing oocyst shedding and environmental contamination is the cornerstone of zoonotic risk reduction [1, 13].

Management of cats: Keep cats indoors to prevent hunting and ingestion of infected prey [16, 30]. Feed only commercial cooked or canned food; avoid raw meat diets [6, 31]. Daily removal of feces from litter boxes (before oocysts sporulate) reduces environmental contamination [13, 19]. Litter boxes should be cleaned with hot water (>70°C) to inactivate oocysts [23].

Environmental hygiene: Oocysts are resistant to most disinfectants but are inactivated by temperatures above 55°C, desiccation, and ammonia-based cleaners [25, 18]. Garden soil and sandboxes should be covered to prevent cat defecation.

Vaccination: No commercial vaccine is currently available for cats. However, gene-edited live-attenuated vaccines have shown promise in experimental models [4]. Advances in antigen discovery, including mRNA-based strategies, are under investigation within a One Health framework [12]. A MIC17A-based vaccine candidate has been evaluated for entero-epithelial stage targeting [26].

Public health education: Cat owners, pregnant women, and immunocompromised individuals should be informed about toxoplasmosis transmission routes [9, 11, 27]. Hand hygiene after handling cat litter and gardening is critical [10, 24]. Serological screening of pregnant women and immunocompromised patients is recommended in endemic areas [9, 25].

The following Mermaid diagram summarizes the decision tree for veterinary management of feline toxoplasmosis:

flowchart TD
    A[Cat presents with clinical signs], > B{Serology + PCR}
    B, >|IgM positive / PCR positive| C[Clinical toxoplasmosis]
    B, >|IgG positive only| D[Latent infection - no treatment]
    C, > E{Severity assessment}
    E, >|Mild| F[Clindamycin PO 4 weeks]
    E, >|Severe (neuro/ocular)| G[Clindamycin + corticosteroids]
    F, > H[Monitor clinical response]
    G, > H
    H, > I{Improvement?}
    I, >|Yes| J[Complete therapy]
    I, >|No| K[Re-evaluate diagnosis / consider alternative]
    D, > L[Preventive counseling]
    L, > M[Indoor confinement, cooked diet, litter hygiene]

References

[1] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[2] Fu YT, Xiao YN, Yi XL, et al. Population genetic structure of zoonotic Toxoplasma gondii in China revealed using multilocus sequence typing. Sci One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42325813/

[3] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[4] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/

[5] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[6] Yanesari MR, Youssefi M, Gharib FZ. Prevalence of Toxoplasma gondii infection in domestic and street cats in Golestan Province, Iran: a comparative study. J Parasit Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42226900/

[7] Rehman FT, Ahmad U, Sardar R, et al. Molecular epidemiology and genetic profiling of Anaplasma ovis, Bartonella sp., and Toxoplasma gondii in domestic cats. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42217308/

[8] Liu WG, Huang J, Maihemuti M, et al. Seroprevalence and molecular detection of toxoplasma gondii in sheep and pigs in Xinjiang Uygur autonomous region, China. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211286/

[9] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[10] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[11] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[12] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[13] Nagamori Y, Whittle A, Warren Z, et al. Prevalence and epidemiologic patterns of feline parasitism detected by fecal examination in the United States, 2023. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42184502/

[14] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[15] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[16] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[17] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[18] Xie F, Xie Y, Yang Y, et al. Loss of TGME49_227100 (Glutaredoxin 5) Disrupts Oocyst Formation and Sporulation in Toxoplasma gondii. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41754403/

[19] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[20] Nguyen NPN, Nguyen TT, Phanpha C, et al. Occurrence of Toxoplasma gondii and Neospora caninum Antibodies in Pet Cats and Dogs in Pathum Thani, Thailand. Trop Med Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42042950/

[21] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[22] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[23] Tachibana Y, Gu X, Sasai M, et al. An in vivo fitness gene of Toxoplasma, MIC11, is essential for PLP1-mediated egress from host cells. Nat Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41935076/

[24] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[25] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[26] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[27] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/

[28] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/

[29] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[30] Hasan MF, Nahar A, Harun AB, et al. Serological and molecular investigation of Toxoplasma gondii in domestic cats in Dhaka City, Bangladesh. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41778096/

[31] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[32] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[33] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[34] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/

[35] Schlax K, Ogonczyk-Makowska D, Mélin M, et al. Seroprevalence of Toxoplasma gondii in pet rabbits (Oryctolagus cuniculus) in France: A pilot study. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741030/